Purpose

Single center, double-masked study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects

Condition

Eligibility

Eligible Ages
Between 18 Years and 65 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Male or female ≥ 18 to ≤ 65 years of age. - In good health, as assessed at Screening by the Investigator from past medical history, physical examination (abbreviated), and laboratory tests. - Does not wear contact lenses, or is willing to refrain from wearing contact lenses for the duration of the study.

Exclusion Criteria

  • Women of childbearing potential or non-vasectomized males with partners of childbearing potential are not eligible unless they are using an effective method of contraception and agree to use an effective method of contraception until at least 30 days after study treatment. - Any medical condition (systemic or ophthalmic) that may, in the opinion of the Investigator, preclude the safe administration of IP, safe participation in this study, or confound the assessment of safety or efficacy. - Unwilling or unable to comply with the study protocol.

Study Design

Phase
Phase 1
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
BL1332 eye drops
  • Drug: BL1332 eye drops
    Taken 1 time
Placebo Comparator
BL1332 Placebo eye drops
  • Drug: BL1332 Placebo eye drops
    Taken 1 time

Recruiting Locations

Site 101
Newport Beach, California 92663

More Details

Status
Recruiting
Sponsor
Bausch & Lomb Incorporated

Study Contact

Celia Busby
9453277624
celia.busby@bausch.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.